Business
KDA Group Completes Acquisition of All ZRX Digital Prescriber Proprietary Rights From ZoomMed
(TheNewswire) Thetford Mines, Quebec - TheNewswire - July 28, 2023 - KD...
About this update from Kda Group Inc.
[{"type":"text","content":"KDA Group Completes Acquisition of All ZRX Digital Prescriber Proprietary Rights From ZoomMed\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Thetford Mines, Quebec -\n \n \n TheNewswire -\n \n \n July 28, 2023\n \n \n \n \n -\n \n \n KDA Group Inc.\n \n \n (TSXV:KDA)\n \n \n (“\n \n \n KDA\n \n \n ” or the\n“\n \n \n Corporation\n \n \n ”) and ZoomMed Inc. (“\n \n \n ZoomMed\n \n \n ”) are\npleased to announce that KDA has completed today the previously\nannounced acquisition, in its press release dated June 30, 2023, of\nall the proprietary rights in the ZRx Digital Prescriber (the\n“\n \n \n ZRx Prescriber\n \n \n ”) held by ZoomMed, in consideration of 10,000,000 Class A\nShares of KDA’s share capital (the “\n \n \n Transaction\n \n \n ”).\n \n \n \n \n Groupe Technologique KDA Inc. (“\n \n \n Tech KDA\n \n \n “), a\nwholly owned subsidiary of the Corporation, acquired in May 2021 the\nownership rights to the ZRx Prescriber to develop, market and operate\nthe ZRx Prescriber in the United States, Europe and the United Kingdom\n(the “\n \n \n Initial\nTerritory\n \n \n ”), in consideration for 20,000,000\nClass A shares of KDA’s share capital. The Corporation expects to\ntransfer its rights in the ZRx Prescriber acquired pursuant to the\nTransaction to Tech KDA, which will enable Tech KDA to significantly\nexpand the Initial Territory for the operation of the ZRx\nPrescriber.\n \n \n \n \n The ZRx Prescriber is an electronic prescriber computer\nand mobile software designed and developed by ZoomMed Médical Inc., a\nwholly owned subsidiary of ZoomMed, for use by healthcare providers\nwho are authorized to prescribe medications and other\ntreatments.\n \n \n \n \n The Transaction is effective as of July 28, 2023, and\nsubject to the final approval from the TSX Venture Exchange. KDA and\nZoomMed are arm’s length parties and no finder’s fee is payable in\nconnection with the Transaction. Full details of the Transaction and\ncertain other matters are set out in ZoomMed’s management\ninformation circular dated June 23, 2023, a copy of which can be found\nunder the profile of ZoomMed on SEDAR+ at\n \n \n \n \n www.sedarplus.ca\n \n \n \n \n .\n \n \n \n \n ABOUT KDA GROUP\n ...